feed,title,long_url,short_url
Benzinga,GENFIT Announces Pivotal Publication of NIS4â„¢ Technology to Identify Patients with At-Risk NASH in The Lancet Gastroenterology & Hepatology,https://www.benzinga.com/pressreleases/20/08/g16937205/genfit-announces-pivotal-publication-of-nis4-technology-to-identify-patients-with-at-risk-nash-in-,https://j.mp/31nlrR9
Benzinga,Launch of a Capital Increase with Shareholders' Preferential Subscription Rights for an Amount of Approximately Eur 330 Million,https://www.benzinga.com/pressreleases/20/08/g16937204/launch-of-a-capital-increase-with-shareholders-preferential-subscription-rights-for-an-amount-of-a,https://j.mp/2Do4FcJ
